Benchmark Forecasts Strong Price Appreciation for IMAX (NYSE:IMAX) Stock

IMAX (NYSE:IMAX) had its target price boosted by research analysts at Benchmark from $42.00 to $44.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Benchmark’s price target suggests a potential upside of 10.36% from the company’s current price.

A number of other research firms have also weighed in on IMAX. Wall Street Zen raised shares of IMAX from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 7th. Rosenblatt Securities reaffirmed a “buy” rating and issued a $47.00 price target on shares of IMAX in a research report on Tuesday. Roth Mkm reiterated a “buy” rating and set a $42.00 price objective on shares of IMAX in a research note on Monday, December 8th. Barrington Research reissued an “outperform” rating and issued a $42.00 price objective on shares of IMAX in a research note on Monday, January 26th. Finally, Wells Fargo & Company increased their target price on IMAX from $40.00 to $47.00 and gave the company an “overweight” rating in a research report on Thursday, December 18th. Ten research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, IMAX has a consensus rating of “Moderate Buy” and a consensus price target of $42.90.

IMAX Price Performance

Shares of IMAX stock traded up $3.35 during mid-day trading on Thursday, hitting $39.87. The stock had a trading volume of 394,836 shares, compared to its average volume of 1,049,858. IMAX has a 12-month low of $20.48 and a 12-month high of $40.25. The firm’s 50-day moving average is $36.23 and its two-hundred day moving average is $33.81. The firm has a market capitalization of $2.14 billion, a P/E ratio of 56.25, a price-to-earnings-growth ratio of 1.91 and a beta of 0.38.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Westfield Capital Management Co. LP acquired a new stake in IMAX in the third quarter worth about $53,141,000. Orbis Allan Gray Ltd raised its position in shares of IMAX by 31.7% in the 2nd quarter. Orbis Allan Gray Ltd now owns 5,113,033 shares of the company’s stock valued at $142,960,000 after purchasing an additional 1,230,267 shares during the last quarter. Divisadero Street Capital Management LP acquired a new stake in IMAX in the 3rd quarter worth approximately $20,975,000. Marsico Capital Management LLC purchased a new stake in IMAX during the 4th quarter worth approximately $18,149,000. Finally, Balyasny Asset Management L.P. acquired a new position in IMAX during the 2nd quarter valued at approximately $12,568,000. 93.51% of the stock is owned by institutional investors and hedge funds.

Key IMAX News

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: Q4 beat: IMAX reported Q4 EPS of $0.58 vs. $0.43 consensus and revenue of $125.2M (up 35% year-over-year), signaling healthy margin and top-line beats that drove investor optimism. IMAX Q4 earnings / MarketBeat
• Positive Sentiment: Tentpole performance: Strong box-office from Avatar: Fire & Ash materially boosted IMAX’s quarter and helped the company reach a record $1.28B global IMAX box office in 2025. ‘Avatar: Fire & Ash’ Lifts IMAX Quarterly Earnings / Variety
• Positive Sentiment: 2026 box-office target and slate expansion: Management outlined a $1.4B global box-office target for 2026 and is expanding premium content and network reach — a clear revenue-growth thesis for investors. IMAX outlines $1.4B 2026 target / Seeking Alpha
• Positive Sentiment: Upcoming premium releases & non‑movie content: IMAX secured exclusive opening-weekend play for Dune 3 and select-market screenings of Avengers Doomsday; Studio Ghibli’s Kiki and live F1 broadcasts will also fill screens and diversify revenue. Dune 3 exclusive / Beebom
• Positive Sentiment: Analyst support: Rosenblatt reiterated a Buy with a $47 price target and Wedbush kept an Outperform, reinforcing the bullish investor narrative. Rosenblatt reiterates Buy / AmericanBankingNews
• Neutral Sentiment: Details and disclosures: Full Q4 earnings call transcript, slide deck and press release are available for investors who want granular operational and guidance color. Q4 2025 earnings call transcript / Seeking Alpha
• Negative Sentiment: Valuation and concentration risk: IMAX trades at a high P/E (~55) and remains dependent on a handful of tentpole releases each year, which can amplify volatility if big releases underperform. IMAX stock profile / MarketBeat

IMAX Company Profile

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.